Due to the inherent possibility of electronic cigarettes causing related lung injuries, approximately 75 multidisciplinary experts have requested the Centers for Disease Control and Prevention to change the name of the illness, as it is misleading and incorrectly implies that all e-cigarette devices can cause this illness, when in fact the only confirmed cause is THC e-cigarette products contaminated with vitamin E acetate.
In 2019, the UK Department of Public Health stated that EVALI was not related to the long-term use of regulated nicotine e-cigarette products. As a result of a rapid public health response, there has been increased awareness among the public about the risks associated with using e-cigarettes or e-cigarette products containing THC.
However, the Centers for Disease Control and Prevention (CDC) emphasized that there is insufficient evidence to rule out the possibility of other chemicals potentially playing a role in EVALI cases, including chemicals from products containing or not containing THC. Research data on e-cigarette products reveal thousands of chemical components, the majority of which remain unidentified.
Dr. Mendelsohn’s research has further indicated that erroneous information about the relationship between e-cigarettes and EVALI could have deadly consequences. He emphasizes the need to correct the ongoing misunderstandings about the cause of EVALI, as incorrect information could lead to public panic and harm public health, not only in Australia, but also in the United States.
Medical experts and public health regulatory agencies around the world have discovered that electronic cigarettes are the most popular aid for quitting or reducing smoking. As a result, they can help smokers transition to better alternatives.
In fact, the public health benefits of electronic cigarettes have been recognized by the National Health Service in the UK and the Ministry of Health in New Zealand, as they have accepted the use of electronic cigarettes to help smokers quit their habit.
The UK government has expressed concern that unfounded fears about electronic cigarettes are preventing smokers from using them as a tool to quit smoking. Similarly, New Zealand's Ministry of Health has launched a public campaign aiming to dispel misconceptions surrounding e-cigarettes and encourage smokers to incorporate them as part of the country's smoke-free 2025 goal.
The US Centers for Disease Control and Prevention (CDC) has recommended that those attempting to quit smoking using e-cigarettes weigh the benefits and risks and avoid using e-cigarettes that contain THC, any kind of modified e-cigarette device, or any substance not approved by the US government. As public health authorities and the general public increasingly recognize the science behind e-cigarettes and support their adoption through thoughtful and balanced regulatory frameworks, e-cigarettes will continue to play a crucial role in helping smokers quit around the world.
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, nor can 2FIRSTS confirm the authenticity or accuracy of its content. The translation of this article is solely for communication and research purposes within the industry.
Due to limitations in translation proficiency, the translated article may not fully reflect the original text. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao or Taiwan-related, or foreign-related remarks and stances.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
